Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • houkto
    Junior Member
    • Sep 2011
    • 5

    #1

    NGS whole genome sequence versus sequence capture for quality control

    Hi there,

    I am trying to compare NGS whole genome sequence data (two strains, one with x26 coverage and the other with x21 coverage) and custom agilent sequence capture of selected regions from the the above mentioned strains but with very high coverage (x10,000). Both data were analysed using the same pipeline.

    Aim:
    To get a percentage of how reliable my NGS data is compared to sequence capture.
    and the way I am thinking of doing it is by either extract the SNPs from NGS data SNPs/indel using the targeted regions that were used in the custom sequence capture and then compared how many snps were missed by the NGS analysis. or I can pull the snps at earlier point of the analysis.

    What I need to know is:
    (a)What i wanted to know is what do you think of this approach, specially i have not seen it yet done by other group yet ? (if it did could you please let me know about this article).

    (b) is there another way of comparing both dataset for quality control

    (c) Also I wanted to know what are other possible benefits from doing such comparison ? if you think it is a good idea?

    Cheers

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 10:13 AM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Working...